Axsome Therapeutics

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. They generate revenue through the research, development, and commercialization of their proprietary drug candidates aimed at treating conditions like depression, migraine, and narcolepsy. Founded in 2012, Axsome has made significant strides with its innovative pipeline, including FDA approvals for some of its treatments. The company's commitment to addressing unmet medical needs in CNS disorders positions it as a key player in the biopharmaceutical industry.

Recent Posts by Axsome Therapeutics

1-20 of 323